Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2006 1
2007 1
2008 2
2009 2
2010 1
2014 5
2015 2
2016 1
2017 1
2018 5
2019 4
2020 10
2021 25
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
The role of intracoronary imaging in translational research.
Montarello NJ, Nelson AJ, Verjans J, Nicholls SJ, Psaltis PJ. Montarello NJ, et al. Cardiovasc Diagn Ther. 2020 Oct;10(5):1480-1507. doi: 10.21037/cdt-20-1. Cardiovasc Diagn Ther. 2020. PMID: 33224769 Free PMC article. Review.
Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Desai RJ, et al. PLoS Med. 2019 Mar 13;16(3):e1002763. doi: 10.1371/journal.pmed.1002763. eCollection 2019 Mar. PLoS Med. 2019. PMID: 30865626 Free PMC article.
These results could help in promoting educational interventions aimed at increasing patient and provider confidence in the ability of generic medicines to manage chronic diseases....
These results could help in promoting educational interventions aimed at increasing patient and provider confidence in the ability of generi …
Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication.
Tangcharoensathien V, Patcharanarumol W, Suwanwela W, Supangul S, Panichkriangkrai W, Kosiyaporn H, Witthayapipopsakul W. Tangcharoensathien V, et al. Int J Health Policy Manag. 2020 Apr 1;9(4):133-137. doi: 10.15171/ijhpm.2019.96. Int J Health Policy Manag. 2020. PMID: 32331492 Free PMC article.
Benefit package is crucial for implementing universal health coverage (UHC). This editorial analyses how the benefit package of the Thai Universal Coverage Scheme (UC Scheme) evolved from an implicit comprehensive package which covered all conditions and interventions (wit …
Benefit package is crucial for implementing universal health coverage (UHC). This editorial analyses how the benefit package of the T …
Making diagnostic tests as essential as medicines.
Velazquez Berumen A, Garner S, Hill SR, Swaminathan S. Velazquez Berumen A, et al. BMJ Glob Health. 2018 Aug 3;3(4):e001033. doi: 10.1136/bmjgh-2018-001033. eCollection 2018. BMJ Glob Health. 2018. PMID: 30116599 Free PMC article. No abstract available.
Reprint of: Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere.
Kalantar-Zadeh K, Li PK, Tantisattamo E, Kumaraswami L, Liakopoulos V, Lui SF, Ulasi I, Andreoli S, Balducci A, Dupuis S, Harris T, Hradsky A, Knight R, Kumar S, Ng M, Poidevin A, Saadi G, Tong A; World Kidney Day Steering Committee. Kalantar-Zadeh K, et al. Nephrol Ther. 2021 Apr;17(2):69-73. doi: 10.1016/j.nephro.2021.02.001. Epub 2021 Mar 23. Nephrol Ther. 2021. PMID: 33741269 French.
It could be supported by regulatory agencies as a metric for quality care or to support labeling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients. ...
It could be supported by regulatory agencies as a metric for quality care or to support labeling claims for medicines and devices. Fu …
Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
Garnock-Jones KP, Keating GM. Garnock-Jones KP, et al. Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Paediatr Drugs. 2009. PMID: 19445548 Review.
Atomoxetine did not differ significantly from or was noninferior to immediate-release methylphenidate in children and adolescents with ADHD with regard to efficacy, and was significantly more effective than standard current therapy (any combination of medicines [excluding …
Atomoxetine did not differ significantly from or was noninferior to immediate-release methylphenidate in children and adolescents with ADHD …
60 results